These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2840296)

  • 21. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term atropine treatment lowers the efficacy of carbachol to stimulate phosphatidylinositol breakdown in the cerebral cortex and hippocampus of rats.
    Goobar L; Bartfai T
    Biochem J; 1988 Mar; 250(3):727-34. PubMed ID: 3390140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the acute stress on agonist-stimulated phosphoinositide hydrolysis in the rat cerebral cortex.
    Morinobu S; Kuwayama N; Kawanami T; Okuyama N; Takahashi M; Totsuka S; Endoh M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):561-70. PubMed ID: 1353631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
    Cossery JM; Gozlan H; Spampinato U; Perdicakis C; Guillaumet G; Pichat L; Hamon M
    Eur J Pharmacol; 1987 Aug; 140(2):143-55. PubMed ID: 2959487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related changes in receptor-mediated phosphoinositide hydrolysis in various regions of rat brain.
    Mundy W; Tandon P; Ali S; Tilson H
    Life Sci; 1991; 49(14):PL97-102. PubMed ID: 1653884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated cocaine administration does not affect 5-HT receptor subtypes (5-HT1A, 5-HT2) in several rat brain regions.
    Javaid JI; Sahni SK; Pandey SC; Davis JM
    Eur J Pharmacol; 1993 Jul; 238(2-3):425-9. PubMed ID: 8405113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological effects of selective 5-HT1a and 5-HT1b ligands in rat hippocampus: comparison to 5-HT.
    Segal M; Azmitia EC; Whitaker-Azmitia PM
    Brain Res; 1989 Nov; 502(1):67-74. PubMed ID: 2531014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1985 Jul; 234(1):195-203. PubMed ID: 2989504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of receptor-coupled phosphoinositide hydrolysis in the rat hippocampus after intradentate colchicine.
    Tandon P; Ali SF; Bonner M; Tilson HA
    J Neurochem; 1989 Oct; 53(4):1117-25. PubMed ID: 2549197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization of agonist-stimulated inositol phospholipid turnover in individual neurons of the rat cerebral cortex and hippocampus.
    Bevilacqua JA; Downes CP; Lowenstein PR
    Neuroscience; 1994 Jun; 60(4):945-58. PubMed ID: 7936213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in the rat hippocampus by activation of protein kinase C.
    Schoepp DD; Johnson BG
    Biochem Pharmacol; 1988 Nov; 37(22):4299-305. PubMed ID: 2904266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine-induced alterations in receptor-stimulated phosphoinositide hydrolysis in the rat hippocampus.
    Tandon P; Harry GJ; Tilson HA
    Brain Res; 1989 Jan; 477(1-2):308-13. PubMed ID: 2539230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.